Fenestrated EVAR using physician-modified stent-grafts for thoraco-abdominal aortic lesions
10.3760/cma.j.issn.1007-631X.2018.03.005
- VernacularTitle:台上体外开窗技术治疗胸腹主动脉病变
- Author:
Yan CHEN
1
;
Jiechang ZHU
;
Xiangchen DAI
;
Yudong LUO
;
Hailun FAN
;
Zhou FENG
;
Yiwei ZHANG
;
Fanguo HU
Author Information
1. 300052,天津医科大学总医院血管外科
- Keywords:
Aortic diseases;
Angioplasty;
Fenestrated stent-graft
- From:
Chinese Journal of General Surgery
2018;33(3):196-200
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate fenestrated endovascular aortic repair (FEVAR) using physician-modified stent-grafts (PMSGs) for thoraco-abdominal aortic lesions.Methods Seven cases of thoraco-abdominal aortic lesions (1 type Ⅲ thoraco-abdominal aortic aneurysm,1 type Ⅳ thoraco-abdominal aortic aneurysm,4 chronic thoraco-abdominal aortic dissection and 1 type Ⅰ endoleak after EVAR due to abdominal aortic aneurysm) were treated with FEVAR from Nov 2016 to Nov 2017.Results FEVAR was performed successfully in all cases.Type Ⅱ and Ⅲ endoleak occurred in 4 cases.One died of acute myocardial infarction 2 days postoperatively.Renal dysfunction deterioration occurred in one case of chronic dissection and improved after the medical treatment.Renal subcapsular hematoma was found in 2 cases postoperatively,and resolved after conservative therapy.Mean follow-up period was 7.2 months,target vessel patency was identified in 5 of the 6 cases.Conclusions FEVAR using PMSGs is a viable alternative to treat thoraco-abdominal aortic lesions.
